XYLO logo

Xylo Technologies Ltd Stock Price

NasdaqCM:XYLO Community·US$6.5m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

XYLO Share Price Performance

US$5.07
2.12 (71.86%)
US$5.07
2.12 (71.86%)
Price US$5.07

XYLO Community Narratives

There are no narratives available yet.

Snowflake Analysis

Excellent balance sheet with low risk.

3 Risks
0 Rewards

Xylo Technologies Ltd Key Details

US$29.9m

Revenue

US$23.2m

Cost of Revenue

US$6.7m

Gross Profit

US$12.7m

Other Expenses

-US$6.0m

Earnings

Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
-4.70
22.38%
-20.19%
39.0%
View Full Analysis

About XYLO

Founded
1999
Employees
38
CEO
Liron Carmel
WebsiteView website
www.medigus.com

Xylo Technologies Ltd, a technology-based company, provides medical-related devices and products in the United States, Europe, Great Britain, Israel, Canada, Asia, and internationally. It operates through Corporate, Online Advertising & Internet Traffic Routing, Online Event Management, and Real-estate and Electronics segments. The company offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. It also provides digital advertising platform; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, it develops wireless vehicle battery charging technologies and modular electronic vehicles. The company was formerly known as Medigus Ltd. and changed its name to Xylo Technologies Ltd in April 2024. Xylo Technologies Ltd was incorporated in 1999 and is based in Tel Aviv, Israel.

Recent XYLO News & Updates

Recent updates

No updates